Expression of the Heat Shock Protein HSP27 in Human Ovarian Cancer

Clinical Cancer Research

Volumn 1, Issue 12, 1995, Pages 1603-1609

  Langdon, Simon P ^a   Rabiasz, Genevieve J ^a   Hirst, Gillian L ^a   King, Roger J B ^b   Hawkins, Richard A ^c   Smyth, John F ^a   Miller, William R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN HSP27; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ANIMALS; CARCINOMA; ESTROGENS; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029586916     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. King, R. J. B., and Coffer, A. I. The generation of antibodies against partially purified estradiol receptor from human myometrium. In: V. C. Jordan (ed.), Estrogen/Antiestrogen Action and Breast Cancer Therapy, pp. 375–394. Madison, WI: University of Wisconsin Press, 1986.
2. King, R. J. B., Finley, J. R., Coffer, A. E., Millis, R. R., and Rubens, R. D. Characterisation and biological relevance of a 29-kDa, oestrogen receptor-related protein. J. Steroid. Biochem., 27: 471–475, 1987.
3. Thor, A., Benz, C., Moore, D., Goldman, E., Edgerton, S., Landry, J., Schwartz, L., Mayall, B., Hickey, E., and Webber, L. A. Stress response protein (srp27) determination in primary human breast carcinomas: clinical, histologic and protein correlations. J. Natl. Cancer Inst., 83: 170–178, 1991.
4. Ciocca, D. R., Adams, D. J., Edwards, D. P., Bjercke, R. J., and McGuire, W. L. Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res., 43: 1204–1210, 1983.
5. Adams, D. J., and McGuire, W. L. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors. Cancer Res., 45: 2445–2449, 1985.
6. Ciocca, D. R., Esterreich, S., Chamness, G. C., McGuire, W. L., and Fuqua, S. A. W. Biological and clinical implications of heat shock protein 27000 (Hsp27): a review. J. Natl. Cancer Inst., 85: 1558–1570, 1993.
7. Love, S., and King, R. J. B. A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br. J. Cancer, 69: 743–748, 1994.
8. Harrison, J. D., Morris, D. L., Ellis, I. O., and Morris, D. L. Estrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br. J. Surg., 78: 334–336, 1991.
9. Dunn, D. K., Whelan, R. D. H., Hill, B., and King, R. J. B. Relationship of HSP27 and oestrogen receptor in hormone sensitive and insensitive cell lines. J. Steroid Biochem. Mol. Biol., 46: 469–479, 1993.
10. Edwards, D. P., Adams, D. J., and Savage, N. Estrogen induced synthesis of specific proteins in human breast cancer cells. Biochem. Biophys. Res. Commun., 93: 804–812, 1980.
11. Ciocca, D. R., Fuqua, S. A. W, Lock-Lim, S., Toft, D. O., Welch, W. J., and McGuire, W. L. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res., 52: 3648–3654, 1992.
12. Fucqua, S. A. W., Blum-Salingaros, M., and McGuire, W. L. Induction of the estrogen-regulated “24K” protein by heat shock. Cancer Res., 49: 4126–4129. 1989.
13. Cano, A., Coffer, A. I., Adatia, R., Millis, R. R., Rubens, R. D., and King, R. J. B. Histochemical studies with an estrogen receptor-related protein in human breast tumors. Cancer Res., 46: 6475–6480, 1986.
14. Ciocca, D. R., Puy, L. A., and Fasoli, L. C. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Cancer Res., 49: 4298–4304, 1989.
15. Ciocca, D. R., Stati, A. O., and Amprine de Castro, M. M. Colocalisation of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue. Breast Cancer Res. Treat., 16: 243–251, 1990.
16. McGuire, W. L., Dressier, L. G., Sledge, G. W., Ramzy, I., and Ciocca, D. R. An estrogen-regulated protein in normal and malignant endometrium. J. Steroid Biochem., 24: 155–159, 1986.
17. Raju, K. S., King, R. J. B., Kaem, J., Dumner, D., Abeler, V. M., Mandalaya, S., and Trope, C. Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer. Int. J. Gynecol. Cancer, 5: 94–100, 1995.
18. Langdon, S. P., Hawkes, M. M., Lawrie, S. S., Hawkins, R. A., Tesdale, A. L., Crew, A. J., Miller, W. R., and Smyth, J. F. Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br. J. Cancer, 62: 213–216, 1990.
19. Langdon, S. P., Ritchie, A., Young, K., Crew, A. J., Sweeting, V., Bramley, T., Hillier, S., Hawkins, R. A., Tesdale, A. L., Smyth, J. F., and Miller, W. R. Contrasting effects of 17β-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer, 55: 459–464, 1993.
20. Langdon, S. P., Hirst, G. L., Miller, E. P., Hawkins, R. A., Tesdale, A. L., Smyth, J. F., and Miller, W. R. The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J. Steroid Biochem. Mol. Biol., 50: 131–135, 1994.
21. Langdon, S. P., Crew, A. J., Ritchie, A. A., Muir, M., Wakeling, A., Smyth, J. F., and Miller, W. R. Growth inhibition of oestrogen receptor- positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Eur. J. Cancer, 30A: 682–686, 1994.
22. Serov, S. F., and Scully, R. E. Histological typing of ovarian tumors. In: International Histological Classification of Tumors, No. 9. Geneva, Switzerland: WHO, 1973.
23. Crew, A. J., Langdon, S. P., Miller, E. P., and Miller, W. R. Mitogenic effects of epidermal growth factor and transforming growth factor-a on EGF-receptor positive human ovarian carcinoma cell lines. Eur. J. Cancer, 28: 337–341, 1992.
24. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal. Biochem., 72: 248–252, 1976.
25. Coffer, A. I., Lewis, K. M., Brockas, A. J., and King, R. J. B. Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res., 45: 3686–3693, 1985.
26. Kimura, E., Enns, R. E., Alcaraz, J. E., Arboleda, J., Slamon, D. J., and Howell, S. B. Correlation of the survival of ovarian cancer patients with messenger RNA expression of the 60-kD heat shock protein HSP-60. J. Clin. Oncol., 11: 891–898, 1993.
27. Huot, J., Roy, G., Lambert, H., Chretien, P., and Landry, J. Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res, 51: 5245–5252, 1991.